Healthtech funding in H2 2023
European Healthtech startup funding raised during H2 2023.
In H2 2023, 222 European Healthtech companies closed 226 funding rounds and raised €4.5B in equity funding (excluding debt and grants), up 29.3% versus H2 2022. Debt rounds added €72M. Netherlands led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 20 Nov 2026.
Equity funding
€4.5B
+29.3% vs H2 2022 · excl. debt & grants · +€72M debt
Funding rounds
226
-30.9% vs H2 2022
Companies
222
Top country
Netherlands
Rank among sectors
#6
9.8% of sector funding
Debt financing
€72M
1.6% of total
Top-10 round share
76.2%
of disclosed capital
Rounds ≥ €100M
4
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, H2 2023 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jul | €279M | 36 |
| Aug | €3.0B | 30 |
| Sep | €391M | 39 |
| Oct | €321M | 44 |
| Nov | €286M | 45 |
| Dec | €251M | 32 |
Top countries
by € raisedHealthtech — top countries by capital, H2 2023 — interactive chart.
Data table
| Healthtech — top countries by capital, H2 2023 | |
|---|---|
| Netherlands | €2.7B |
| UK | €881M |
| France | €295M |
| Denmark | €163M |
| Belgium | €119M |
| Switzerland | €91M |
| Germany | €87M |
| Sweden | €82M |
Stage mix
by € raisedHealthtech — stage mix, H2 2023 — interactive chart.
Data table
| Healthtech — stage mix, H2 2023 | |
|---|---|
| Other | €3.6B |
| Series A | €423M |
| Series B | €207M |
| Series C | €121M |
| Seed | €95M |
| Debt | €72M |
| Grant | €25M |
| Pre-Seed | €13M |
| Early VC | €1.0M |
| Series D+ | €716k |
Exits & M&A
15 Acquisition15 exits · €6.3B disclosed.
| Abcam | Acquisition | Aug 2023 | €5.2B |
| MedAlliance | Acquisition | Oct 2023 | €1.1B |
Top deals
largest disclosed rounds in H2 2023| Company | Stage | Date | Amount |
|---|---|---|---|
| Philips | Other | Aug 2023 | €2.6B |
| Compass Pathways | Other | Aug 2023 | €261M |
| CMR Surgical | Other | Sep 2023 | €154M |
| Aqemia | Other | Dec 2023 | €129M |
| Agomab Therapeutics | Series C | Oct 2023 | €95M |
| EyeBiotech | Series A | Nov 2023 | €61M |
| Neko Health | Series A | Jul 2023 | €60M |
| Corti | Series B | Sep 2023 | €56M |
| MinervaX | Other | Oct 2023 | €54M |
| Causaly | Series B | Jul 2023 | €54M |
| Lightcast Discovery | Series B | Aug 2023 | €45M |
| In Ovo | Debt | Nov 2023 | €40M |
| Automata Technologies | Other | Oct 2023 | €38M |
| MYCB1 | Other | Sep 2023 | €31M |
| Bactolife | Series A | Aug 2023 | €30M |
Top investors
most active in H2 2023, by deal count- High-Tech Gründerfonds (HTGF)5 deals
- Bpifrance4 deals
- Calm Storm Ventures4 deals
- European Innovation Council (EIC)4 deals
- Octopus Ventures4 deals
- Verve Ventures4 deals
- BGF3 deals
- Fongit Innovation Fund (FIF)3 deals
- LIFTT3 deals
- Mercia Ventures3 deals